Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2011 1
2015 1
2016 4
2017 1
2018 2
2019 2
2020 5
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE-/- and LDLr-/- Mice by a Mechanism That Includes Inflammatory Pathways.
Rakipovski G, Rolin B, Nøhr J, Klewe I, Frederiksen KS, Augustin R, Hecksher-Sørensen J, Ingvorsen C, Polex-Wolf J, Knudsen LB. Rakipovski G, et al. JACC Basic Transl Sci. 2018 Nov 21;3(6):844-857. doi: 10.1016/j.jacbts.2018.09.004. eCollection 2018 Dec. JACC Basic Transl Sci. 2018. PMID: 30623143 Free PMC article.
UCP1-independent glucose-lowering effect of leptin in type 1 diabetes: only in conditions of hypoleptinemia.
Zouhar P, Rakipovski G, Bokhari MH, Busby O, Paulsson JF, Conde-Frieboes KW, Fels JJ, Raun K, Andersen B, Cannon B, Nedergaard J. Zouhar P, et al. Among authors: rakipovski g. Am J Physiol Endocrinol Metab. 2020 Jan 1;318(1):E72-E86. doi: 10.1152/ajpendo.00253.2019. Epub 2019 Nov 19. Am J Physiol Endocrinol Metab. 2020. PMID: 31743040 Free PMC article.
Liraglutide treatment improves endothelial function in the Ldlr-/- mouse model of atherosclerosis and affects genes involved in vascular remodelling and inflammation.
Bjørnholm KD, Skovsted GF, Mitgaard-Thomsen A, Rakipovski G, Tveden-Nyborg P, Lykkesfeldt J, Povlsen GK. Bjørnholm KD, et al. Among authors: rakipovski g. Basic Clin Pharmacol Toxicol. 2021 Jan;128(1):103-114. doi: 10.1111/bcpt.13486. Epub 2020 Oct 8. Basic Clin Pharmacol Toxicol. 2021. PMID: 32896073 Free article.
A neutralizing antibody against DKK1 does not reduce plaque formation in classical murine models of atherosclerosis: Is the therapeutic potential lost in translation?
Rakipovski G, Rolin B, Barascuk N, Lund HE, Bjørn Bonde MF, Djordjevic D, Wulff-Larsen PG, Petersen M, Kirk RK, Hultman K, Manfe V, Blume N, Zahn S, Lengquist M, Maegdefessel L, Hovingh GK, Conde-Knape K, Hedin U, Matic L, Nyberg M. Rakipovski G, et al. Atherosclerosis. 2020 Dec;314:1-9. doi: 10.1016/j.atherosclerosis.2020.10.001. Epub 2020 Oct 6. Atherosclerosis. 2020. PMID: 33129080
16 results